Sinovac Biotech, Ltd (SVA) Posts Q1 Loss of 10c/Share

Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q1 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6 million versus the consensus estimate of $7.3 million.

For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c